everlinQ endoAVF System

DEVICE3 trials

Sponsors

C. R. Bard

Conditions

Chronic Kidney DiseaseChronic Kidney Diseases

Unknown Phase

everlinQ endoAVF Post Market Study

TerminatedNCT02682420

C. R. BardChronic Kidney Disease

Start: 2016-09-20End: 2019-08-31Updated: 2025-12-11

everlinQ Endovascular Access System Enhancements (EASE) Study

CompletedNCT03708770

C. R. BardChronic Kidney Diseases

Start: 2015-07-27End: 2017-06-19Updated: 2025-12-11

everlinQ Endovascular Access Systems Enhancements (EASE-2) Study

CompletedNCT03708562

C. R. BardChronic Kidney Diseases

Start: 2017-10-16End: 2018-12-12Updated: 2025-12-11